BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9149873)

  • 1. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
    Kurilla MG
    Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
    Falkner FG; Moss B
    J Virol; 1988 Jun; 62(6):1849-54. PubMed ID: 3130492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant selectable marker for the construction of recombinant poxviruses.
    Boyle DB; Coupar BE
    Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.
    Isaacs SN; Kotwal GJ; Moss B
    Virology; 1990 Oct; 178(2):626-30. PubMed ID: 2219714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient method for generating poxvirus recombinants in the absence of selection.
    Rice AD; Gray SA; Li Y; Damon I; Moyer RW
    Viruses; 2011 Mar; 3(3):217-32. PubMed ID: 21494427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli gpt as a positive and negative selectable marker in embryonal stem cells.
    Spring KJ; Mattick JS; Don RH
    Biochim Biophys Acta; 1994 Jun; 1218(2):158-62. PubMed ID: 8018715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus.
    Scheiflinger F; Dorner F; Falkner FG
    Arch Virol; 1998; 143(3):467-74. PubMed ID: 9572548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puromycin resistance (pac) gene as a selectable marker in vaccinia virus.
    Sánchez-Puig JM; Blasco R
    Gene; 2000 Oct; 257(1):57-65. PubMed ID: 11054568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.
    Pfleiderer M; Falkner FG; Dorner F
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2957-62. PubMed ID: 8847500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy.
    Boulanger D; Baier R; Erfle V; Sutter G
    J Virol Methods; 2002 Oct; 106(1):141-51. PubMed ID: 12367739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of human hepatoma cells with targeted insertions of a gpt selectable marker in the alpha 1-antitrypsin locus.
    Porter MB; Fournier RE
    Somat Cell Mol Genet; 1996 Jul; 22(4):311-27. PubMed ID: 9000174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of recombinant vaccinia virus strains using single-stranded DNA insertion vectors.
    Wilson EM; Hodges WM; Hruby DE
    Gene; 1986; 49(2):207-13. PubMed ID: 3569915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants.
    Zhou J; Crawford L; Sun XY; Frazer IH
    Gene; 1991 Nov; 107(2):307-12. PubMed ID: 1660832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of recombinant MVA using F13L selection.
    Sánchez-Puig JM; Lorenzo MM; Blasco R
    Methods Mol Biol; 2012; 890():93-111. PubMed ID: 22688762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.17. PubMed ID: 18265124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of recombinant vaccinia viruses on the basis of plaque formation.
    Blasco R; Moss B
    Gene; 1995 Jun; 158(2):157-62. PubMed ID: 7607536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a selectable nef-defective live-attenuated human immunodeficiency virus expressing Escherichia coli gpt gene.
    Tanuri A; Jesus da Costa L; Brindeiro R; Ramos CA; Pau CP; Rayfield MA
    Virology; 2000 Mar; 268(1):79-86. PubMed ID: 10683329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus.
    Lorenzo MM; Blasco R
    Biotechniques; 1998 Feb; 24(2):308-13. PubMed ID: 9494734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.